Galapagos NV
GLPG
#4582
Rank
S$2.75 B
Marketcap
S$41.74
Share price
0.37%
Change (1 day)
13.67%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): S-$0.42

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is S-$0.44. In 2024 the company made an earnings per share (EPS) of S$1.50 a decrease over its 2023 EPS that were of S$4.56.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.42-128.33%
2024S$1.50-67.16%
2023S$4.56-199.64%
2022S-$4.5899.03%
2021S-$2.30-68.98%
2020S-$7.41-298.06%
2019S$3.74-554.64%
2018S-$0.82-77.18%
2017S-$3.61-326.21%
2016S$1.59-134.19%
2015S-$4.66-371.34%
2014S$1.72-445.98%
2013S-$0.5032.88%
2012S-$0.37-82.07%
2011S-$2.09-817.9%
2010S$0.2912.73%
2009S$0.26-120.79%
2008S-$1.24-37.67%
2007S-$1.9939.64%
2006S-$1.4228.17%
2005S-$1.116.25%
2004S-$1.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
S$3.90-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$13.41-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.76-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
S$1.74-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
S-$0.78 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.35-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$0.81-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$4.62-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$9.76-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA